TITLE

Size (and structure) matters

AUTHOR(S)
Reicheg, Alan
PUB. DATE
July 2008
SOURCE
Pharmaceutical Representative;Jul2008, Vol. 13 Issue 7, p24
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the U.S. pharmaceutical industry marketers combine advanced analytics with the knowledge and expertise of regional sales representatives to enhance their productivity. It notes that advanced analytics create new opportunities without disrupting sales and marketing plans. Pharmaceutical and biotechnology companies are finding more cost-effective and targeted ways to approach sales and marketing.
ACCESSION #
32996764

 

Related Articles

  • Right in front of your eyes. LeVine, Paul; Zucker, Jeanne // Pharmaceutical Representative;Feb2007, Vol. 37 Issue 2, p28 

    The article offers information on how pharmaceutical representatives could build a solid partnership with their customers in the U.S. The sales personnel's anticipation of a patient's questions helps strengthen their rapport with clients. In this way, it could result to a representatives' brand...

  • Pharmaceuticals Selling Strategies in the Chinese Market.  // China Chemical Reporter;12/16/2009, Vol. 20 Issue 35, p6 

    The article discusses the selling strategies of pharmaceuticals in the Chinese market. It mentions that marketing strategies must probe the right products for the right target markets. Pharmaceutical markets are subdivided into three categories, large scale and county-level hospitals, famous...

  • Business Planning.  // Pharmaceutical Representative;Apr2010, Vol. 40 Issue 4, p28 

    The article focuses on business planning in selling pharmaceutical products. It says that effective strategies and realistic goals can be developed if a representative views his or her territory as a system. It states that identifying different types of customers and needs is important before...

  • Impact players. Ceaser, Orlando // Pharmaceutical Representative;Feb2007, Vol. 37 Issue 2, p30 

    The article discusses the qualities of a good pharmaceutical representative. They included some characteristics like the innate talent of being a salesperson, eagerness to learn, and attentiveness to the fundamentals. He must also possessed high standards, creativity and innovation, persistence...

  • Where have all the Scientists Gone?  // Pharmaceutical Executive;Mar2011, Vol. 31 Issue 3, p16 

    The article presents the view of the author on the Mechanism of Action (MOA) concept of marketing in the pharmaceutical industry in the U.S. According to the author, the MOA can be generated to support scientific approach in pharmaceutical marketing. The author also mentions that the MOA can...

  • Breaking the Routine. McCarthy, Justin // Pharmaceutical Representative;Oct2009, Vol. 39 Issue 10, p22 

    The article discusses how pharmaceutical representatives break the monotonous routine and repetitiveness of marketing the same products to physicians. The author states that breaking the routine requires using time and energy but the return on investment may be worth the effort. He adds that...

  • Scientific marketing: Creating the agenda. Henriksen, Shila; Skou, Philip // Journal of Medical Marketing;Jan2005, Vol. 5 Issue 1, p27 

    Deals with techniques to help pharmaceutical marketers in their efforts to involve healthcare professionals in the scientific marketing discipline. Core elements of scientific marketing; Process involved in developed a scientific marketing strategy; Approaches to providing a true value of...

  • Vyvanse prepares to lead ADHD class. McGuire, Stephen // Medical Marketing & Media;Aug2007, Vol. 42 Issue 8, p24 

    The article reports on the move of Shire PLC to gather 560 sales personnel on the launching of its attention-deficit hyperactivity disorder (ADHD) drug Vyvanse. According to Matthew Cabrey, Shire's spokesman, the Vyvanse sales team is comprised of individual who have experienced selling other...

  • A Managed Care Strategy. Wood, Leana // Pharmaceutical Executive;Jun2011, Vol. 31 Issue 6, p102 

    The author discusses steps for pharmaceutical marketers on how to promote their first-in-class drug in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics